BRAFTOVI
BRAFTOVI
Approved
DIN Number
02513099
Drug Class
Human
Market Date
Jul 5, 2021
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02513099
AIG Number0162787001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EC03 ENCORAFENIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ENCORAFENIBActive
Strength: 75 MG
Monograph: ENCORAFENIB